Clinical Trial Update: Mixed-methods Protocol for the WiSSPr Study

View source ↗

Summary

A completed clinical trial protocol outlining a mixed-methods approach for studying uptake of pre-exposure prophylaxis (PrEP) for HIV prevention in Zambia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Centre for Infectious Disease Research in Zambia | Conditions: PrEP Uptake | Status: COMPLETED